Cargando…
Ion Channels in Pulmonary Hypertension: A Therapeutic Interest?
Pulmonary arterial hypertension (PAH) is a multifactorial and severe disease without curative therapies. PAH pathobiology involves altered pulmonary arterial tone, endothelial dysfunction, distal pulmonary vessel remodeling, and inflammation, which could all depend on ion channel activities (K(+), C...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214085/ https://www.ncbi.nlm.nih.gov/pubmed/30322215 http://dx.doi.org/10.3390/ijms19103162 |
_version_ | 1783367920919773184 |
---|---|
author | Lambert, Mélanie Capuano, Véronique Olschewski, Andrea Sabourin, Jessica Nagaraj, Chandran Girerd, Barbara Weatherald, Jason Humbert, Marc Antigny, Fabrice |
author_facet | Lambert, Mélanie Capuano, Véronique Olschewski, Andrea Sabourin, Jessica Nagaraj, Chandran Girerd, Barbara Weatherald, Jason Humbert, Marc Antigny, Fabrice |
author_sort | Lambert, Mélanie |
collection | PubMed |
description | Pulmonary arterial hypertension (PAH) is a multifactorial and severe disease without curative therapies. PAH pathobiology involves altered pulmonary arterial tone, endothelial dysfunction, distal pulmonary vessel remodeling, and inflammation, which could all depend on ion channel activities (K(+), Ca(2+), Na(+) and Cl(−)). This review focuses on ion channels in the pulmonary vasculature and discusses their pathophysiological contribution to PAH as well as their therapeutic potential in PAH. |
format | Online Article Text |
id | pubmed-6214085 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62140852018-11-14 Ion Channels in Pulmonary Hypertension: A Therapeutic Interest? Lambert, Mélanie Capuano, Véronique Olschewski, Andrea Sabourin, Jessica Nagaraj, Chandran Girerd, Barbara Weatherald, Jason Humbert, Marc Antigny, Fabrice Int J Mol Sci Review Pulmonary arterial hypertension (PAH) is a multifactorial and severe disease without curative therapies. PAH pathobiology involves altered pulmonary arterial tone, endothelial dysfunction, distal pulmonary vessel remodeling, and inflammation, which could all depend on ion channel activities (K(+), Ca(2+), Na(+) and Cl(−)). This review focuses on ion channels in the pulmonary vasculature and discusses their pathophysiological contribution to PAH as well as their therapeutic potential in PAH. MDPI 2018-10-14 /pmc/articles/PMC6214085/ /pubmed/30322215 http://dx.doi.org/10.3390/ijms19103162 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Lambert, Mélanie Capuano, Véronique Olschewski, Andrea Sabourin, Jessica Nagaraj, Chandran Girerd, Barbara Weatherald, Jason Humbert, Marc Antigny, Fabrice Ion Channels in Pulmonary Hypertension: A Therapeutic Interest? |
title | Ion Channels in Pulmonary Hypertension: A Therapeutic Interest? |
title_full | Ion Channels in Pulmonary Hypertension: A Therapeutic Interest? |
title_fullStr | Ion Channels in Pulmonary Hypertension: A Therapeutic Interest? |
title_full_unstemmed | Ion Channels in Pulmonary Hypertension: A Therapeutic Interest? |
title_short | Ion Channels in Pulmonary Hypertension: A Therapeutic Interest? |
title_sort | ion channels in pulmonary hypertension: a therapeutic interest? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214085/ https://www.ncbi.nlm.nih.gov/pubmed/30322215 http://dx.doi.org/10.3390/ijms19103162 |
work_keys_str_mv | AT lambertmelanie ionchannelsinpulmonaryhypertensionatherapeuticinterest AT capuanoveronique ionchannelsinpulmonaryhypertensionatherapeuticinterest AT olschewskiandrea ionchannelsinpulmonaryhypertensionatherapeuticinterest AT sabourinjessica ionchannelsinpulmonaryhypertensionatherapeuticinterest AT nagarajchandran ionchannelsinpulmonaryhypertensionatherapeuticinterest AT girerdbarbara ionchannelsinpulmonaryhypertensionatherapeuticinterest AT weatheraldjason ionchannelsinpulmonaryhypertensionatherapeuticinterest AT humbertmarc ionchannelsinpulmonaryhypertensionatherapeuticinterest AT antignyfabrice ionchannelsinpulmonaryhypertensionatherapeuticinterest |